UNIGE document Scientific Article
previous document  unige:108546  next document
add to browser collection
Title

Impact of CD14 Polymorphisms on Anti-Apolipoprotein A-1 IgG-Related Coronary Artery Disease Prediction in the General Population

Authors
Antiochos, Panagiotis
Marques-Vidal, Pedro
show hidden authors show all authors [1 - 12]
Published in Arteriosclerosis, Thrombosis, and Vascular Biology. 2017, vol. 37, no. 12, p. 2342-2349
Abstract We aimed to determine whether autoantibodies against apoA-1 (apolipoprotein A-1; anti-apoA-1 IgG) predict incident coronary artery disease (CAD), defined as adjudicated incident myocardial infarction, angina, percutaneous coronary revascularization, or bypass grafting, in the general population. We further investigated whether this association is modulated by a functional CD14 receptor single nucleotide polymorphism.
Keywords AdultApolipoprotein A-I/immunologyAutoantibodies/bloodBiomarkers/bloodChi-Square DistributionCoronary Artery Disease/blood/epidemiology/genetics/immunologyFemaleGene FrequencyGenetic Association StudiesGenetic Predisposition to DiseaseHeterozygoteHomozygoteHumansImmunoglobulin G/bloodIncidenceKaplan-Meier EstimateLipopolysaccharide Receptors/genetics/immunologyMaleMiddle AgedMultivariate AnalysisPhenotypePolymorphism, Single NucleotideProportional Hazards ModelsProspective StudiesRisk AssessmentRisk FactorsSwitzerland/epidemiologyTime Factors
Identifiers
PMID: 29074586
Full text
Article (Published version) (647 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Chimie et protéomique clinique (270)
Citation
(ISO format)
ANTIOCHOS, Panagiotis et al. Impact of CD14 Polymorphisms on Anti-Apolipoprotein A-1 IgG-Related Coronary Artery Disease Prediction in the General Population. In: Arteriosclerosis, Thrombosis, and Vascular Biology, 2017, vol. 37, n° 12, p. 2342-2349. https://archive-ouverte.unige.ch/unige:108546

17 hits

0 download

Update

Deposited on : 2018-09-26

Export document
Format :
Citation style :